About
Podocyte-targeting Kidney Disease Treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
136
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06466135Lead Sponsor
Study of WAL0921 in Patients With Glomerular Kidney Diseases
PHASE2Recruiting
96 participants
Started: Jul 2, 2024 · Completed: Mar 31, 2026
NCT05891366Lead Sponsor
Single Ascending Dose Study of WAL0921 in Healthy Subjects
PHASE1Completed
40 participants
Started: May 31, 2023 · Completed: Jan 9, 2024
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...